News Archive

The Middle Atlantic Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MARCE) is offering a BSL-3 Training Course at the University of Maryland School of Medicine in Baltimore, MD on October 6-8, 2009.

The University of Virginia will be hosting the MARCE Bioinformatics Workshop on February 18, 2009.

Dr. Geddes, Professor and Director of the Institute of Fluorescence and member of the Middle Atlantic Regional Center of Excellence (MARCE) Diagnostics Research Program, received the Daily Records' "Innovator of the Year" award on October 15, 2008. The award was given to Dr. Geddes for his MARCE project on a 100-copy, 20-second Anthrax diagnostic sensing platform.

For more information, click here

The MARCE Investigators Fall Meeting has been scheduled for Monday, November 3, 2008. This meeting is open to all MARCE members, and will be held at the Turf Valley Resort near Baltimore.

BSL-3 Training Course - MARCE
May 6 - 8, 2008
University of Maryland School of Medicine

Please view the attached document for details on the MARCE Request for Proposals.

RCE Network Diagnostics Workshop
“Biology and Medicine Meet Engineering and Physics”
March 3-4, 2008
Los Angeles (near LAX)
Second Program Announcement

This one-week course will be held at the University of Maryland at Baltimore Monday, January 28 - Friday, Feb. 1. It is co-hosted by the National Biosafety and Biocontainment Training Program (NBBTP) and the Middle Atlantic Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MARCE).

The MARCE will once again have the opportunity to apply for additional support for projects within the Center. These “New Opportunities” funds are not part of the MARCE’s original operational budget, but are intended for use by NIAID to fund new components and activities within the Regional Centers of Excellence. These funds will be applied to objectives such as: enhancing the capabilities of the Centers and the Biodefense Network, encouraging inter-Center activities, and providing additional research, product development, and training opportunities. It is important to remember that one of the goals for the MARCE is to develop vaccines, therapeutics, and diagnostics that are targeted to the Category A-C agents. Projects exhibiting real novelty and genuine innovation will be given extra consideration.

University of Maryland School of Medicine, Baltimore MD

Beyond “Biosafety 101”: Operator’s Guide for a BSL-3

To match the increasing interest in BSL-3 research, a comprehensive training focusing on the operations of these laboratories is needed. The University of Maryland School of Medicine, Department of Environmental Health and Safety, and the Middle Atlantic Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MARCE) designed an interactive course consisting of both lectures and hands-on activities covering issues related to laboratory safety operations for BSL-3 laboratories.